This Article Full Text Full Text (PDF) All Versions of this Article: 38/12/3266    most recent STROKEAHA.107.490003v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Chaichana, K. L. Articles by Tamargo, R. J. Search for Related Content PubMed PubMed Citation Articles by Chaichana, K. L. Articles by Tamargo, R. J. Pubmed/NCBI databases Gene GEO Profiles HomoloGene Nucleotide Protein UniGene Substance via MeSH Related Collections Cerebral Aneurysm, AVM, & Subarachnoid hemorrhage Genetics of Stroke

(Stroke. 2007;38:3266.)
© 2007 American Heart Association, Inc.

Original Contributions

Haptoglobin 2-2 Genotype Determines Chronic Vasospasm After Experimental Subarachnoid Hemorrhage

Kaisorn L. Chaichana, BS; Andrew P. Levy, MD, PhD; Rachel Miller-Lotan, PhD; Sophia Shakur, BS Rafael J. Tamargo, MD, FACS

From Department of Neurosurgery (K.L.C., S.S., R.J.T.), the Johns Hopkins University School of Medicine, Baltimore, Md; Department of Medicine (A.P.L., R.M.-L.), Technion-Israel Institute of Technology, Haifa, Israel.

Correspondence to Rafael J. Tamargo, MD, FACS, Professor of Neurosurgery, The Johns Hopkins Hospital, Department of Neurosurgery, Meyer 8-181, 600 N. Wolfe Street, Baltimore, MD 21287. E-mail rtamarg{at}jhmi.edu

Background and Purpose— Chronic cerebral arterial vasospasm is the leading cause of morbidity and mortality after aneurysmal subarachnoid hemorrhage (SAH). Not all cases of SAH, however, develop chronic vasospasm. Inflammation, specifically leukocyte–endothelial cell interactions, appears to be critical in vasospasm development. Haptoglobin (Hp) is a serum protein that limits the extent of inflammation after a hemorrhagic event. An individual’s Hp genotype may predict the severity of the inflammatory response during a hemorrhagic event, and consequently modulate the risk for vasospasm.

Methods— Sixty mice (Hp 1-1, n=30; Hp 2-2, n=30) underwent injection of either autologous blood or normal saline solution into the cisterna magna. An additional 30 mice (15 per genotype) served as controls. The extent and manifestations of vasospasm were assessed by measuring lumen patency, quantifying activity levels, and counting the number of vessel-infiltrated macrophages/neutrophils at 24 hours after injection, which corresponds to the time of peak vasospasm in mice.

Results— Genetically modified Hp 2-2 mice with SAH had significantly lower basilar artery lumen patencies (mean±SEM; 52.9±1.9% vs 82.3±1.3%; P<0.01), reduced activity levels (0.8±0.3 vs 2.4±0.2; P<0.01), and increased macrophage/neutrophil counts in the subarachnoid space (31.2±6.3 vs 8.8±1.7, P<0.01) as compared with wild-type Hp 1-1 mice.

Conclusions— These findings suggest that the Hp 2-2 genotype is critical for the development of severe vasospasm, which typically occurs 24 hours after SAH in mice.

Key Words: haptoglobin • subarachnoid hemorrhage • vasospasm